Page last updated: 2024-11-06

phentolamine and Paraneoplastic Syndromes

phentolamine has been researched along with Paraneoplastic Syndromes in 1 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirby, BD1
Ham, J1
Fairley, HB1
Benowitz, N1
Schambelan, M1

Other Studies

1 other study available for phentolamine and Paraneoplastic Syndromes

ArticleYear
Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.
    The Western journal of medicine, 1983, Volume: 139, Issue:2

    Topics: Adrenal Gland Neoplasms; Adult; Anesthesia, Intravenous; Diagnosis, Differential; Glucagon; Hormones

1983